Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast.

The British Journal of Surgery
H HamedR D Rubens

Abstract

In a prospective randomized study, patients with pleural effusions secondary to breast carcinoma were randomly allocated to be treated by pleurodesis using either intracavitary talc or bleomycin. For 25 assessable treatments in 22 patients, recurrence of effusion was observed in 5 of 15 (33 per cent) of the bleomycin group compared with none in the talc group. It is concluded that talc is superior to bleomycin in controlling pleural effusions secondary to breast carcinoma, but bleomycin may have a role in patients unfit for general anaesthesia or with extensive disease elsewhere.

References

Jun 1, 1987·Cancer Treatment Reviews·I S Fentiman
Sep 1, 1986·European Journal of Cancer & Clinical Oncology·I S FentimanJ L Hayward
Apr 15, 1981·Cancer·I S FentimanJ L Hayward
Apr 1, 1982·The British Journal of Surgery·I S FentimanJ L Hayward
Jan 23, 1965·British Medical Journal·E H PORTER

❮ Previous
Next ❯

Citations

Jan 1, 1997·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A TürlerM Walter
Dec 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L BjermerR Henriksson
Jul 1, 1997·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·P BaasC A Hoefnagel
Jun 29, 2004·Current Opinion in Pulmonary Medicine·Sophie D WestY C Gary Lee
May 4, 2011·Current Opinion in Pulmonary Medicine·Helen E DaviesY C Gary Lee
Jun 9, 2004·Respirology : Official Journal of the Asian Pacific Society of Respirology·Y C Gary Lee, Richard W Light
Nov 9, 2000·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society
May 3, 2003·Thorax·M HenryUNKNOWN Pleural Diseases Group, Standards of Care Committee, British Thoracic Society
Oct 23, 1997·Chest·M M DeCampD J Sugarbaker
Jun 1, 1994·Chest·W C Miller, K M Unger
Mar 15, 2005·Chest·Carolyn M DreslerUNKNOWN Radiation Therapy Oncology Group
Aug 25, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kimihide YoshidaNagahiro Saijo
Jun 21, 2014·Respirology : Official Journal of the Asian Pacific Society of Respirology·Rajesh ThomasY C Gary Lee
Apr 1, 1993·Cancer Treatment Reviews·D W Miles, R K Knight
Feb 1, 1993·The Annals of Thoracic Surgery·M A BrestickerR Greene
Aug 1, 1994·Chest·L KennedyS A Sahn
Jan 26, 2006·The Journal of Thoracic and Cardiovascular Surgery·Giuseppe CardilloMassimo Martelli
Jul 1, 1992·Chest·P Mathur, W J Martin
Nov 22, 2013·The Cochrane Database of Systematic Reviews·Paul H S Shaw, Roshan Agarwal
May 9, 2016·The Cochrane Database of Systematic Reviews·Amelia O CliveNick Maskell
Nov 1, 1991·The British Journal of Surgery·J S Chambers
Jan 1, 1996·Scandinavian Journal of Thoracic and Cardiovascular Surgery·D Weissberg, Y Refaely
Apr 22, 2020·The Cochrane Database of Systematic Reviews·Alexandra DipperAmelia O Clive
Jul 1, 1994·The Annals of Pharmacotherapy·C O Andrews, M L Gora
Jan 1, 1997·Journal of Cancer Research and Clinical Oncology·P AthanassiadouM Mavrikakis
Mar 1, 1997·Cancer Control : Journal of the Moffitt Cancer Center·C A Tate
Nov 23, 2020·General Thoracic and Cardiovascular Surgery·Eleftherios T BeltsiosNikolaos Panagiotopoulos
Jan 16, 2003·Chest·Paul A KvaleUNKNOWN American College of Chest Physicians
Jul 1, 1998·Clinics in Chest Medicine·S A Sahn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.